In a study with over 10 million plan members, Truven Health Analytics ranked musculoskeletal (MSK) conditions as the top cost driver for self-funded employers. The study found that MSK spend outpaced spend for cancer, cardiovascular disease, women’s health and reproductive care, or type 2 diabetes.
Employers’ MSK spend is so high because MSK care is often highly medicalized and interventional using excessive diagnostics, treatments without clear evidence and with high cost and little outcome data.
40% of patients are misdiagnosed and 50% of patients are back in the system within 12 months of treatment.
To solve this ever escalating cost, progressive employers are deploying a collection of disconnected point solutions – ranging from wellness, Virtual PT, chronic back pain, second opinion, centers of excellence (COEs), and more. However, this mishmash of fragmented musculoskeletal care delivery programs are not integrated, aligned or accountable to deliver better outcomes at lower costs.